A Phase I, Open-label, Single-center Study to Assess the Pharmacokinetics of a Single Oral Dose of VIMOVO (250 mg Naproxen/20 mg Esomeprazole)in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 21 Jun 2012
At a glance
- Drugs Esomeprazole/naproxen (Primary)
- Indications Ankylosing spondylitis; Osteoarthritis; Rheumatoid arthritis
- Focus Pharmacokinetics
- 21 Jun 2012 Actual end date (Jun 2011) added as reported by ClinicalTrials.gov.
- 21 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 Jun 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.